CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	$ 342	$ 1,192
Accounts receivable, net of allowance for credit losses of $20 and $15 as of March 31, 2020 and December 31, 2019, respectively	972	1,063
Inventories	126	123
Prepaid expenses and other current assets	120	112
Total current assets	1,560	2,490
Property, plant and equipment, net	1,461	1,453
Operating lease right-of-use assets	512	518
Goodwill	6,694	6,619
Intangible assets, net	1,138	1,121
Investments in equity method investees	496	482
Other assets	188	160
Total assets	12,049	12,843
Liabilities and Stockholders' Equity
Accounts payable and accrued expenses	981	1,041
Current portion of long-term debt	3	804
Current portion of long-term operating lease liabilities	145	145
Total current liabilities	1,129	1,990
Long-term debt	4,033	3,966
Long-term operating lease liabilities	409	413
Other liabilities	699	711
Commitments and contingencies
Redeemable noncontrolling interest	76	76
Quest Diagnostics stockholders’ equity:
Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2020 and December 31, 2019; 217 shares issued as of both March 31, 2020 and December 31, 2019	2	2
Additional paid-in capital	2,738	2,722
Retained earnings	8,197	8,174
Accumulated other comprehensive loss	(58)	(39)
Treasury stock, at cost; 83 and 84 shares as of March 31, 2020 and December 31, 2019, respectively	(5,222)	(5,218)
Total Quest Diagnostics stockholders' equity	5,657	5,641
Noncontrolling interests	46	46
Total stockholders' equity	5,703	5,687
Total liabilities and stockholders' equity	$ 12,049	$ 12,843